APCER Life Sciences Expands Integrated Pharmacovigilance Services with Oracle Argus Cloud Service

NEW DELHI–(BUSINESS WIRE)–#APCER–APCER Life Sciences, the preferred pharmacovigilance (PV) services provider for pharmaceutical and biotech companies seeking compliance and safety management solutions across the product life cycle, has adopted Oracle Argus Cloud Service to deliver Integrated PV services. Argus is a leading SaaS solution for processing, analyzing, and reporting adverse event cases originating for pre/post … [Read more…]

Royalty Rates for Pharmaceuticals & Biotechnology, 2022 Analysis Report – Real-deal Royalty Rates, License Fees, and Milestone Payment Benchmarks – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Royalty Rates for Pharmaceuticals & Biotechnology, 9th Edition” report has been added to ResearchAndMarkets.com’s offering. Royalty Rates for Pharmaceuticals & Biotechnology features more real-deal royalty rates, license fees, and milestone payment benchmarks than any other publication. The ninth edition of Royalty Rates for Pharmaceuticals & Biotechnology contains hundreds of royalty rates and other … [Read more…]

Humanetics Corporation Expands Long-Haul COVID-19 Trial to Additional Sites

Four sites now enrolling patients in study of new drug to mitigate long COVID lung injury MINNEAPOLIS–(BUSINESS WIRE)–Humanetics Corporation (Humanetics) has added two additional clinical sites to its long-haul COVID-19 study, which is focused on patients who were treated for severe COVID-19 and face the possible risk that their respiratory complications will lead to long-term … [Read more…]

Improv 2 Improve Changes Classrooms Through Play

i2i launches a new website offering SEL game packs that inspire joy-filled classrooms LAKE WORTH BEACH, Fla.–(BUSINESS WIRE)–Improv 2 Improve (i2i) is on a mission to create joy-filled classrooms with play at their center. i2i’s classroom game packs provide children with brain breaks while creating an avenue for social emotional learning (SEL). Students have so … [Read more…]

XIFIN Appoints John Kelly to Chief Information Officer

Former PatientKeeper and Cigna executive brings extensive technology leadership experience including customer-focused innovation and merging organizations for operational success SAN DIEGO–(BUSINESS WIRE)–XIFIN announced today that John Kelly has joined the company as chief information officer. In this role, a first for the company, Kelly will advance product and service cohesion and operations as XIFIN integrates … [Read more…]

Modivcare Announces Acquisition of Guardian Medical Monitoring

DENVER–(BUSINESS WIRE)–Modivcare Inc. (“Modivcare” or the “Company”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving patient outcomes, today announced the Company’s Remote Patient Monitoring (RPM) Segment has acquired Guardian Medical Monitoring, LLC (“GMM”) from its parent company, Guardian Alarm. Guardian Medical Monitoring is a … [Read more…]

Dr. Brandee Pappalardo Joins Fresenius Kabi as Chief Medical Officer for North America

LAKE ZURICH, Ill.–(BUSINESS WIRE)–#CMO–Fresenius Kabi announced today that Brandee Pappalardo, Ph.D., M.P.H. has joined the company as senior vice president and Chief Medical Officer for North America. Dr. Pappalardo reports to John Ducker, president and CEO of Fresenius Kabi in North America and is a member of the company’s North America executive committee. Fresenius Kabi … [Read more…]

Marinus Pharmaceuticals to Present at Upcoming Medical and Investor Conferences

RADNOR, Pa.–(BUSINESS WIRE)–$MRNS #MarinusPharma—Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that management will participate in the following investor and medical conferences in May and June: Citi Biotech Virtual Co-Panel Day May 18 at 3:30 p.m. ET. This presentation will be closed … [Read more…]

Propanc Biopharma Undertaking PRP Manufacturing & Development for Human Use

Novel Proenzyme Pharmaceutical Formulation to be Administered by Intravenous (I.V.) Injection in World First, Phase I First-In-Human Study in Advanced Cancer Patients MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that the Company is undertaking … [Read more…]

Article Reviews the Evolution of Arthroscopy from its Invention in 1912 to the Dawn of the Wireless ArthroFree™ Era

CLEVELAND–(BUSINESS WIRE)–#JOEI_TheJournal–A recent history of arthroscopy by Dr. James S. Williams, Jr., and Dr. Asheesh Gupta reports that while there have been numerous incremental advances in arthroscopic camera technology over the last half-century, the current systems remain largely unchanged. Surgeons are tethered to the surgical tower by a power cable and by a light cord … [Read more…]